Magenta Therapeutics Alpha and Beta Analysis
| MGTADelisted Stock | USD 0.82 0.03 3.80% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Magenta Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Magenta Therapeutics over a specified time horizon. Remember, high Magenta Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Magenta Therapeutics' market risk premium analysis include:
Beta 0.6 | Alpha 0.0381 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Magenta |
Magenta Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Magenta Therapeutics market risk premium is the additional return an investor will receive from holding Magenta Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Magenta Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Magenta Therapeutics' performance over market.| α | 0.04 | β | 0.60 |
Magenta Therapeutics Fundamentals Vs Peers
Comparing Magenta Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Magenta Therapeutics' direct or indirect competition across all of the common fundamentals between Magenta Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Magenta Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Magenta Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Magenta Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Magenta Therapeutics to competition |
| Fundamentals | Magenta Therapeutics | Peer Average |
| Return On Equity | -0.65 | -0.31 |
| Return On Asset | -0.29 | -0.14 |
| Current Valuation | (32.66 M) | 16.62 B |
| Shares Outstanding | 60.66 M | 571.82 M |
| Shares Owned By Insiders | 2.23 % | 10.09 % |
| Shares Owned By Institutions | 62.63 % | 39.21 % |
| Number Of Shares Shorted | 383.03 K | 4.71 M |
Magenta Therapeutics Opportunities
Magenta Therapeutics Return and Market Media
The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Magenta Sets Up Dianthus Merger After Stopping Blood Cancer Trial Due To Patient Death | 05/03/2023 |
2 | SHAREHOLDER INVESTIGATION Halper Sadeh LLC Investigates MGTA, CHRA, STSA | 05/18/2023 |
About Magenta Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Magenta or other delisted stocks. Alpha measures the amount that position in Magenta Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Magenta Therapeutics Upcoming Company Events
As portrayed in its financial statements, the presentation of Magenta Therapeutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Magenta Therapeutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Magenta Therapeutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Magenta Therapeutics. Please utilize our Beneish M Score to check the likelihood of Magenta Therapeutics' management manipulating its earnings.
| 2nd of November 2023 Upcoming Quarterly Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View | |
| 30th of June 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Magenta Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Consideration for investing in Magenta Stock
If you are still planning to invest in Magenta Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Magenta Therapeutics' history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |